Sigmak Lifesciences partners with pharmaceutical importers, manufacturers, and distributors in Kenya to supply WHO-GMP sourced injectable formulations, active pharmaceutical ingredients, and specialty chemical intermediates. Kenya is a major East African pharmaceutical hub, with product registration and import oversight managed by the Pharmacy and Poisons Board (PPB) within the broader EAC (East African Community) regional framework.
The injectable portfolio covers anti-malarials, antibiotics, analgesics, anti-infectives, vitamins, cardiovascular agents, and essential medicines in ampoule, vial, and dry powder formats. COA, COPP, and stability data documentation is available to support PPB registration submissions and import requirements.
Kenya's role as a regional distribution hub means many customers use Sigmak's supply programs for onward distribution across Uganda, Tanzania, Rwanda, and other East African markets. Sigmak supports cross-border supply planning and documentation for EAC partner states.